Caribou Biosciences Inc - Çeyreklik Finansal İstatistikler (NASDAQ:CRBU) | MetaTrader

Tam grafiği aç

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

İşletme faaliyetlerinden elde edilen nakit -35.47 M-36.73 M-28.26 M-25.18 M-20.82 M -110.99 M Yatırım faaliyetlerinden elde edilen nakit 15.93 M49.38 M24.04 M10.85 M17.97 M 102.24 M Finansman faaliyetlerinden elde edilen nakit 3.86 M468 K6 000277 K4.07 M 4.82 M Serbest nakit akışı -35.99 M-37.77 M-28.68 M-25.3 M-20.61 M -112.35 M

Haberler

Three Best Genomics Stocks for Your Portfolio in 2026

Sarepta Therapeutics (SRPT) Soars 35.0%: Is Further Upside Left in the Stock?

Caribou Biosciences: Antlers Up For The Allogenic CAR-T Bet Trading At Cash Value

Is CareCloud (CCLD) Outperforming Other Medical Stocks This Year?

Truist, Caribou Biosciences için Al tavsiyesini yineledi, hedef 7 dolar

Truist reiterates Buy on Caribou Biosciences stock, $7 target

Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Tops Revenue Estimates

Caribou Biosciences kazancı $0,04 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek

Caribou Biosciences earnings beat by $0.04, revenue topped estimates

EyePoint (EYPT) Reports Q4 Loss, Tops Revenue Estimates

Urogen Pharma (URGN) Reports Q4 Loss, Beats Revenue Estimates

Syndax Pharmaceuticals (SNDX) Reports Q4 Loss, Tops Revenue Estimates